AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35

Authors: Pasternak, GW
Citation: Gw. Pasternak, Incomplete cross tolerance and multiple mu opioid peptide receptors, TRENDS PHAR, 22(2), 2001, pp. 67-70

Authors: King, M Su, W Chang, A Zuckerman, A Pasternak, GW
Citation: M. King et al., Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs, NAT NEUROSC, 4(3), 2001, pp. 268-274

Authors: Abbadie, C Pasternak, GW
Citation: C. Abbadie et Gw. Pasternak, Differential in vivo internalization of MOR-1 and MOR-1C by morphine, NEUROREPORT, 12(14), 2001, pp. 3069-3072

Authors: Abbadie, C Pasternak, GW Aicher, SA
Citation: C. Abbadie et al., Presynaptic localization of the carboxy-terminus epitopes of the mu opioidreceptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord, NEUROSCIENC, 106(4), 2001, pp. 833-842

Authors: Mathis, JP Mandyam, CD Altememi, GF Pasternak, GW Standifer, KM
Citation: Jp. Mathis et al., Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells, NEUROSCI L, 299(3), 2001, pp. 173-176

Authors: King, MA Bradshaw, S Chang, AH Pintar, JE Pasternak, GW
Citation: Ma. King et al., Potentiation of opioid analgesia in dopamine(2) receptor knock-out mice: Evidence for a tonically active anti-opioid system, J NEUROSC, 21(19), 2001, pp. 7788-7792

Authors: Mogil, JS Pasternak, GW
Citation: Js. Mogil et Gw. Pasternak, The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family, PHARM REV, 53(3), 2001, pp. 381-415

Authors: Pan, YX Xu, A Mahurter, L Bolan, E Xu, MM Pasternak, GW
Citation: Yx. Pan et al., Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene, P NAS US, 98(24), 2001, pp. 14084-14089

Authors: Pasternak, GW
Citation: Gw. Pasternak, Insights into mu opioid pharmacology - The role of mu opioid receptor subtypes, LIFE SCI, 68(19-20), 2001, pp. 2213-2219

Authors: Silva, RM Hadjimarkou, MM Rossi, GC Pasternak, GW Bodnar, RJ
Citation: Rm. Silva et al., beta-endorphin-induced feeding: Pharmacological characterization using selective opioid antagonists and antisense probes in rats, J PHARM EXP, 297(2), 2001, pp. 590-596

Authors: Neilan, CL Nguyen, TMD Schiller, PW Pasternak, GW
Citation: Cl. Neilan et al., Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, ahighly potent and selective mu-opioid peptide, EUR J PHARM, 419(1), 2001, pp. 15-23

Authors: Shane, R Lazar, DA Rossi, GC Pasternak, GW Bodnar, RJ
Citation: R. Shane et al., Analgesia elicited by OFQ/nociceptin and its fragments from the amygdala in rats, BRAIN RES, 907(1-2), 2001, pp. 109-116

Authors: Mathis, JP Rossi, GC Pellegrino, MJ Jimenez, C Pasternak, GW Allen, RG
Citation: Jp. Mathis et al., Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities, BRAIN RES, 895(1-2), 2001, pp. 89-94

Authors: Mei, JF Pasternak, GW
Citation: Jf. Mei et Gw. Pasternak, Molecular cloning and pharmacological characterization of the rat sigma(1)receptor, BIOCH PHARM, 62(3), 2001, pp. 349-355

Authors: Abbadie, C Gultekin, SH Pasternak, GW
Citation: C. Abbadie et al., Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord, NEUROREPORT, 11(9), 2000, pp. 1953-1957

Authors: Abbadie, C Pan, YX Drake, CT Pasternak, GW
Citation: C. Abbadie et al., Comparative immunohistochemical distributions of carboxy terminus epitopesfrom the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS, NEUROSCIENC, 100(1), 2000, pp. 141-153

Authors: Pasternak, GW Pan, YX
Citation: Gw. Pasternak et Yx. Pan, Antisense mapping: Assessing functional significance of genes and splice variants, METH ENZYM, 314, 2000, pp. 51-60

Authors: Kolesnikov, YA Chereshnev, I Pasternak, GW
Citation: Ya. Kolesnikov et al., Analgesic synergy between topical lidocaine and topical opioids, J PHARM EXP, 295(2), 2000, pp. 546-551

Authors: Letchworth, SR Mathis, JP Rossi, GC Bodnar, RJ Pasternak, GW
Citation: Sr. Letchworth et al., Autoradiographic localization of I-125[Tyr(14)]orphanin FQ/nociceptin and I-125[Tyr(10)]orphanin FQ/nociceptin(1-11) binding sites in rat brain, J COMP NEUR, 423(2), 2000, pp. 319-329

Authors: Abbadie, C Pan, YX Pasternak, GW
Citation: C. Abbadie et al., Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: Evidence for region-specific processing, J COMP NEUR, 419(2), 2000, pp. 244-256

Authors: Pan, YX Xu, J Bolan, E Chang, A Mahurter, L Rossi, G Pasternak, GW
Citation: Yx. Pan et al., Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F, FEBS LETTER, 466(2-3), 2000, pp. 337-340

Authors: Silva, RM Rossi, GC Mathis, JP Standifer, KM Pasternak, GW Bodnar, RJ
Citation: Rm. Silva et al., Morphine and morphine-6 beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats, BRAIN RES, 876(1-2), 2000, pp. 62-75

Authors: Stein, JA Znamensky, V Baumer, F Rossi, GC Pasternak, GW Bodnar, RJ
Citation: Ja. Stein et al., Mercaptoacetate induces feeding through central opioid-mediated mechanismsin rats, BRAIN RES, 864(2), 2000, pp. 240-251

Authors: Schuller, AGP King, MA Zhang, JW Bolan, E Pan, YX Morgan, DJ Chang, A Czick, ME Unterwald, EM Pasternak, GW Pintar, JE
Citation: Agp. Schuller et al., Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1, NAT NEUROSC, 2(2), 1999, pp. 151-156

Authors: Zhu, YX King, MA Schuller, AGP Nitsche, JF Reidl, M Elde, RP Unterwald, E Pasternak, GW Pintar, JE
Citation: Yx. Zhu et al., Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice, NEURON, 24(1), 1999, pp. 243-252
Risultati: 1-25 | 26-35